Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was downgraded by research analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued to clients and investors on Saturday. A number of other brokerages have also…
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded at Wall Street Zen
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research note issued to investors on Saturday. Can BioMarin Stock Live Up to Wall Street's High…
California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN
California State Teachers Retirement System grew its position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) by 1,605.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange…
Spyglass Pharma (NASDAQ:SGP) Upgraded to 'Moderate Buy' at Raymond James Financial
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by Raymond James Financial to a 'moderate buy' rating in a research note issued to investors on Friday, Zacks.com reports. Separately, Weiss Ratings initiated coverage on shares of…
NervGen Pharma (NASDAQ:NGEN) Stock Rating Lowered by Wall Street Zen
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'strong sell' rating in a research note issued to investors on Saturday. Other equities analysts have also recently…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Lowered to 'Strong Sell' Rating by Zacks Research
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was downgraded by investment analysts at Zacks Research from a 'hold' rating to a 'strong sell' rating in a report released on Thursday, Zacks.com reports. Several other equities analysts have…
Assenagon Asset Management S.A. Has $1.16 Million Holdings in BridgeBio Pharma, Inc. $BBIO
Assenagon Asset Management S.A. lowered its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 64.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,620 shares of the company's…
Health Care Down on Growth Doubts - Health Care Roundup
Health-care companies fell amid doubts about the growth outlook for the sector. Pfizer shares were more or less flat after Albert Bourla, chief executive of the Big Pharma company, bought $1 million worth of shares, the latest major insider…
Are Mega-Mergers Back?
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: AstraZeneca + BMS? Why merge now? Rising interest rates? The market's reaction SpaceX earnings ahead Can Uber…
Johnson & Johnson Stock: Quality, Doesn't Deserve A Mid-20s Multiple Right Now (NYSE:JNJ)
Johnson & Johnson has delivered a 28% total return YTD, outperforming SPY and XLV, but now trades at a premium valuation. Despite solid Q2 results and raised FY 2026 guidance, JNJ's stock is deemed fully priced, warranting a reiterated hold rating.
CBRE: A Diversified Real Estate Brand Worth Holding, As Q2 Saw Meaningful Growth (CBRE)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Should You Subscribe to Horizon Industrial Parks IPO?
The IPO of Horizon Industrial Parks (HIPL), the owner and operator of industrial and logistics infrastructure, opens for subscription on Monday. The Blackstone-backed company aims to raise ₹2,600 crore through a fresh issue of shares…
PM Modi set a target of featuring 50 Indian companies in Fortune 500
Prime Minister Narendra Modi on Saturday changed the scale of India's ambition by setting a target of bringing 50 companies among Fortune 500 companies and an Indian bank among top global banks. In his address to the nation from the ramparts of the…
India Inc throws up a pleasant surprise in Q1 as compared to gloom at the start of the quarter
Under the full glare of the Middle East conflict, India Inc's performance paints an optimistic picture despite relatively flat earnings growth. Of the 4,220 companies that had reported results till Friday, revenue and PAT grew 21 per cent and 14…
Best Healthcare Stocks To Follow Now - August 15th
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, and Stryker are the five Healthcare stocks to watch today, according to MarketBeat's stock…
Receive a Daily briefing on Pharma Industry News
Get Started